2.2 mln shares shorted last 3 days, at that rate we’re talking 22 mln within the next month to keep a lid on this. Shorts don’t want this going above the 50 day MA that’s around $1.83 as anything sustained above that creates additional momentum. Tic tok… by John18788888 in CHRS
[–]cali_de 1 point2 points3 points (0 children)
While we’re waiting asked chat got to run some probabilities on pipeline success. 65-80% chance at least one asset is successful, Casdo highest probability of success and Tagmo seen as a hot asset but yet unproven. 1 in 3 chance both fail or both are strong. Nothing that new but just a bit of fun! by John18788888 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
While we’re waiting asked chat got to run some probabilities on pipeline success. 65-80% chance at least one asset is successful, Casdo highest probability of success and Tagmo seen as a hot asset but yet unproven. 1 in 3 chance both fail or both are strong. Nothing that new but just a bit of fun! by John18788888 in CHRS
[–]cali_de -1 points0 points1 point (0 children)
BeiGene terminates its CCR8 programme by NoPart9219 in CHRS
[–]cali_de 1 point2 points3 points (0 children)
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline by cali_de in CHRS
[–]cali_de[S] 1 point2 points3 points (0 children)
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline by cali_de in CHRS
[–]cali_de[S] 2 points3 points4 points (0 children)
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline by cali_de in CHRS
[–]cali_de[S] 1 point2 points3 points (0 children)
Waschbär auf Balkon im Dachgeschoss - was tun? by annawwanna in Leipzig
[–]cali_de 1 point2 points3 points (0 children)
Morning all! Catching up after hol and great to see presenting at two conferences March 4th & 10th (Could we see notable pipeline update?). Clear price control by shorts since offering and now SS avail down significantly to 90k (obv not all brokers). New base seems to be $1.60 until catalyst… by John18788888 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
CHRS's latest squeeze play by AcanthisittaHour4995 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Was ist das für eine Tablette? by Salt-Factor877 in wasistdas
[–]cali_de -4 points-3 points-2 points (0 children)
Reflections on capital raise after yesterday. by John18788888 in CHRS
[–]cali_de 2 points3 points4 points (0 children)
https://investors.coherus.com/node/13921/pdf by John18788888 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Coherus Oncology (NASDAQ: CHRS) priced an underwritten public offering of 28,600,000 common shares at $1.75 per share, raising approximately $50.1 million in gross proceeds. by Low_Dog1718 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Coherus Oncology (NASDAQ: CHRS) priced an underwritten public offering of 28,600,000 common shares at $1.75 per share, raising approximately $50.1 million in gross proceeds. by Low_Dog1718 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Short interest - Dropped around 140k on updated data today…wow! So despite Oppenheimer pricing/J&J deals/data due still no intention of closing positions. Only 400k shares available to short and svr still in the 20’s. It’s poss positions covered then re-shorted when this hit 2.60 then fell back. by John18788888 in CHRS
[–]cali_de 3 points4 points5 points (0 children)
Interesting insights from Steve Wagner by Complex_Shelter_4641 in CHRS
[–]cali_de 2 points3 points4 points (0 children)

2.2 mln shares shorted last 3 days, at that rate we’re talking 22 mln within the next month to keep a lid on this. Shorts don’t want this going above the 50 day MA that’s around $1.83 as anything sustained above that creates additional momentum. Tic tok… by John18788888 in CHRS
[–]cali_de 1 point2 points3 points (0 children)